logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuta Yamanaka

Kansai Medical University Hospital
H指数:9
被引数:226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of primary granulocyte colony-stimulating factor prophylaxis in patients with small-cell lung cancer receiving first-line platinum–etoposide plus a programmed death-ligand 1 inhibitor: A multicenter retrospective observational study

小细胞肺癌患者接受一线铂类–依托泊苷联合程序性死亡配体1抑制剂治疗时，初级粒细胞集落刺激因子预防的疗效与安全性：一项多中心回顾性观察性研究

Lung Cancer
IF4.4
2026-10-190
OA
Shuhei Teranishi; Yuki Misumi; Takuma Ishihara; Yuta Yamanaka; Daiki Murata; Tomofumi Hirose; Ryosuke Ochiai; Kento Takagi; Yuko Higashi; Yusuke Hamakawa; Satoshi Ikeda; Naoki Furuya; Yoshiro Nakahara; Satoru Miura; Katsuhiko Naoki
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan

KRAS G12C突变型晚期非小细胞肺癌的临床轨迹：一项日本单中心队列研究

Respiratory Investigation
IF2
2026-05-010
PRE
Okazaki, Yuta; Yoshioka, Hiroshige; Ikoma, Tatsuki; Araki, Keigo; Makihara, Natsuno; Kitagawa, Mai; Nagata, Yutaro; Fujii, Kazuki; Okuno, Yukiko; Kamisako, Keisuke; Nakanishi, Kentaro; Ikeda, Yume; Yoshida, Kiyori; Nakahama, Kahori; Takeyasu, Yuki; Katsushima, Utae; Yamanaka, Yuta; Ikeda, Satoshi; Kurata, Takayasu
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis
Lung Cancer
IF4.4
2026-02-040
PRE
Hidetoshi Hayashi; Byoung Chul Cho; Yu Jung Kim; Se-Hoon Lee; Pongwut Danchaivijitr; Adlinda Alip; Hailin Xiong; Soon-Hin How; Gee-Chen Chang; James Chih-Hsin Yang; Yuta Yamanaka; Mehmet Ali Nahit Şendur; Kumar Prabhash; Koichi Azuma; Alianu Akawung; Elizabeth Fennema; Xiaodan Tang; Sujay Shah; Seema Sethi; Shun Lu
Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology

为什么选择Cemiplimab？在PD-L1表达超高水平且伴有鳞状组织学的非小细胞肺癌一线治疗中定义一个独特的治疗定位

Cancers
IF4.4
2026-01-170
OAAI
Satoshi Ikeda; Keigo Araki; Mai Kitagawa; Natsuno Makihara; Yutaro Nagata; Kazuki Fujii; Kiyori Yoshida; Tatsuki Ikoma; Kahori Nakahama; Yuki Takeyasu; Utae Katsushima; Yuta Yamanaka; Takayasu Kurata
Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study

肺癌免疫预后指数在PD-L1低表达/阴性肿瘤的非小细胞肺癌患者接受化疗免疫治疗中的影响：一项真实世界多中心回顾性研究

ESMO Open
IF8.3
2025-11-200
OAAI
A. Yoshimura; T. Takeda; K. Tanimura; Y. Chihara; H. Kawachi; Y. Yamanaka; N. Tamiya; R. Honda; T. Yamada; K. Uryu; S. Shiotsu; H. Yoshioka; T. Yamada; T. Kurata; K. Takayama
Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial

肺癌患者癌症治疗前的慢速运动训练与持续力量生成及有氧运动的联合效应（START-lung）：一项可行性试点试验

BMC Cancer
IF3.4
2025-10-030
OAAI
Utae Katsushima; Takuya Fukushima; Jiro Nakano; Kazuki Fujii; Yutaro Nagata; Keisuke Kamisako; Yukiko Okuno; Kiyori Yoshida; Tatsuki Ikoma; Yuki Takeyasu; Yuta Yamanaka; Hiroshige Yoshioka; Takayasu Kurata; Eisuke Ochi
Midterm Outcomes of Selective Aortic Side Branch Embolisation Guided by Four Dimensional Flow Sensitive Magnetic Resonance Imaging to Prevent Aneurysm Sac Enlargement due to Type II Endoleak in Patients with Abdominal Aortic Aneurysm

中期结果：通过四维血流敏感磁共振成像引导的选择性主动脉侧支栓塞，以预防腹主动脉瘤患者因Ⅱ型内漏导致的瘤体增大

European Journal of Vascular and Endovascular Surgery
IF6.8
2025-08-070
PRE
Yusuke Endo; Masaki Sano; Kazuto Katahashi; Kazunori Inuzuka; Yuta Yamanaka; Toshiyuki Ojima; Naoki Unno; Hiroya Takeuchi
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2024-06-173
OAAI
Yagishita, Shigehiro; Yamanaka, Yuta; Kurata, Takayasu; Watanabe, Kageaki; Hosomi, Yukio; Horinouchi, Hidehito; Ohe, Yuichiro; Nakahara, Yoshiro; Naoki, Katsuhiko; Asao, Tetsuhiko; Takahashi, Kazuhisa; Saeki, Sho; Sakagami, Takuro; Nakashima, Kazuhisa; Tsubata, Yukari; Fujita, Yu; Wakui, Hiroshi; Furuta, Megumi; Konishi, Jun Sakakibara; Ohuchi, Mayu; Ando, Yuichi; Mizugaki, Hidenori; Hamada, Akinobu
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study
FRONTIERS IN ONCOLOGY
IF3.3
2024-01-260
OAAI
Yoshimura, Akihiro; Takeda, Takayuki; Kataoka, Nobutaka; Tanimura, Keiko; Fukui, Mototaka; Chihara, Yusuke; Takei, Shota; Kawachi, Hayato; Nakanishi, Kentaro; Yamanaka, Yuta; Tamiya, Nobuyo; Honda, Ryoichi; Okura, Naoko; Yamada, Takahiro; Uryu, Kiyoaki; Murai, Junji; Shiotsu, Shinsuke; Yoshioka, Hiroshige; Yamada, Tadaaki; Kurata, Takayasu; Takayama, Koichi

研究方向

暂未获取到该数据
T
Takayasu Kurata
H 指数:59论文数:462被引数:3.5万
H
Hiroshige Yoshioka
H 指数:49论文数:356被引数:1.6万
Y
Yuki Takeyasu
H 指数:10论文数:71被引数:1,184
T
Tetsuhiko Asao
H 指数:21论文数:197被引数:1,470
Y
Yukio Hosomi
H 指数:34论文数:388被引数:9,231
Y
Yu Fujita
H 指数:40论文数:135被引数:5,907
Y
Yukari Tsubata
H 指数:19论文数:208被引数:1,878
K
Kageaki Watanabe
H 指数:13论文数:95被引数:613
S
Shigehiro Yagishita
H 指数:22论文数:190被引数:1,468
T
Tatsuki Ikoma
H 指数:5论文数:88被引数:122